Labiotech.eu

Prader Willi syndrome: five much-anticipated therapies poised for approval

Discover five promising Prader-Willi syndrome therapies climbing the clinical ladder and nearing FDA approval in the coming ...
The Globe and Mail

Prader-Willi Syndrome Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Novo Nordisk, Pfizer, Sandoz, Harmony Biosciences, Soleno ...

The Key Prader-Willi Syndrome Companies in the market include - Novo Nordisk, Pfizer, Sandoz, Harmony Biosciences, Soleno Therapeutics, Harmony Biosciences, ACADIA Pharmaceuticals, Aardvark ...
Local 12 WKRC Cincinnati

NKY student with Prader-Willi syndrome fulfills dream of playing for basketball team

BOONE COUNTY, Ky. (WKRC) - It was a dream come true for a senior at Ryle High School who loves sports. Jacob Arnold is usually the team manager for the Raiders basketball team, but he got the nod to ...
Business Wire

Acadia Pharmaceuticals Announces Phase 3 Development Candidate ACP-101 (intranasal carbetocin) for Prader-Willi Syndrome

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the addition of a new Phase 3 development candidate to its rare disease portfolio, ACP-101 (intranasal carbetocin ...
Monthly Prescribing Reference

Diazoxide Choline Designated Breakthrough Therapy for Prader-Willi Syndrome

Findings showed DCCR significantly improved hyperphagia in patients with severe hyperphagia at baseline. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...

Aardvark Therapeutics Expands Phase 3 HERO Trial Eligibility for ARD-101 in Prader-Willi Syndrome After FDA Protocol Alignment

Aardvark Therapeutics Inc. (NASDAQ:AARD) is one of the best young stocks with huge upside potential. On October 8, Aardvark ...
KMBC Kansas City

Never feeling full: 4-year-old metro girl lives with Prader Willi Syndrome

WE’LL TALK TO YOU LATER. WELL, IMAGINE EATING ENOUGH MAYBE TOO MUCH, BUT NEVER FEELING FULL. THAT’S WHAT A NORTHLAND TODDLER LIVES WITH EVERY DAY. AND THIS WORLD WHERE DISEASE DAY CAME DECISIONS DONNA ...
Nasdaq

Soleno Therapeutics to Present Research Findings at 2025 International Prader-Willi Syndrome Conference

Soleno Therapeutics, Inc. announced its participation in the 2025 United In Hope: International Prader-Willi Syndrome Conference, scheduled for June 24-28, 2025, in Phoenix, AZ. The company will ...
Business Wire

Acadia Pharmaceuticals Initiates Pivotal Phase 3 Study of Carbetocin (ACP-101) for the Treatment of Hyperphagia in Prader-Willi Syndrome

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the initiation of the Phase 3 COMPASS PWS study evaluating the efficacy and safety of carbetocin nasal spray (ACP ...
Healio

FDA rejects new drug application for internasal carbetocin to treat Prader-Willi syndrome

Please provide your email address to receive an email when new articles are posted on . The FDA’s Division of Psychiatry has rejected a new drug application for treating hyperphagia, anxiousness and ...
Business Insider

Tonix Pharmaceuticals Plans to Initiate Prader-Willi Syndrome Phase 2 Trial of TNX-2900 (Intranasal Potentiated Oxytocin) in 2026

Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with Prader-Willi Syndrome under a cleared IND TNX-2900 ...
Mena FN

Prader-Willi Syndrome Market To Experience Notable Growth In Forecast Span By 2034, Delveinsight Predicts Novo Nordisk, Pfizer, Sandoz, Harmony Biosciences, Soleno Therapeutics ...

(MENAFN- GetNews) The Key Prader-Willi Syndrome Companies in the market include - Novo Nordisk, Pfizer, Sandoz, Harmony Biosciences, Soleno Therapeutics, Harmony Biosciences, ACADIA Pharmaceuticals, ...